Clinical Trials Browser

Active not recruiting × Gliosarcoma × Radiotherapy × Clear all

NCT03197506 2025-04-06

Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma

Phase 2 Active not recruiting

Glioblastoma, Gliosarcoma